学会誌・資料 Journal

日本知財学会誌 第2巻第1号掲載

バイオベンチャーと特許ポートフォリオ
Patent Strategy in Bio-Venture


森下 竜一
Ryuichi Morishita
日本知財学会誌 Vol.2 No.1 p.65-70(2005-11-20)
Journal of Intellectual Property Association of Japan Vol.2 No.1 p.65-70(2005-11-20)

<要旨>
大学発ベンチャー1000 社構想がスタートして3 年になるが,目標の1000 社を2005 年には既に超えた.大学発ベンチャーの30 %は,医療・バイオ分野で大学発ベンチャーの主流を占めてきている.一方で,IT 系とバイオ系のベンチャーの違いも明らかになってきた.IT 系ベンチャーが比較的短期間で技術を実用化できるのに対し,バイオ系はデス・バレー(死の谷)と呼ばれる技術の実用化までの端境期が長く,多くの資金を必要とする.そのため,デス・バレーを乗り切るために知的財産戦略が重要である.従って,ベンチャーの成功を握る鍵は,知的財産を基盤として大企業との連携をいかにして築くかにある.本稿では,バイオベンチャーにおける知的財産戦略において概略を説明する.
<Summary>
Three years have passed since the “Project to establish 1000 University Startups” was implemented and now, in the year 2005, the number of such startups has exceeded the initial target, and in the mainstream we see companies coming mostly from the medical and bio fields, which make up 30 percent of the total number. The different paths taken by IT and bio startups have also become quite clear. Whereas an IT venture take a relatively short time to apply its technologies, the bio venture needs a longer time to realize its products, which accordingly will take up more capital.
Therefore, in dealing with this longer process, sometimes referred to as “crossing the Death Valley,” the company's intellectual property strategy has become increasingly important, and the key to its success lies in the way it collaborates with large corporations, using intellectual properties as its base technology. Here, I will outline the intellectual property strategies of these bio venture companies.